Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses.
about
Psychomotor retardation in depression: a systematic review of diagnostic, pathophysiologic, and therapeutic implications.The other face of depression, reduced positive affect: the role of catecholamines in causation and cureTreatment-resistant depression: critique of current approachesAre atypical antipsychotic drugs also atypical antidepressants?Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.Neurocognitive predictors of antidepressant clinical response.Is it safe to use antidepressants after a stroke?Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.Antidepressant drug development: Focus on triple monoamine reuptake inhibition.Depression and Parkinson's disease: a conceptual challenge.Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.The depressions of Alzheimer's disease: sorting, pharmacotherapy, and clinical advice.Neuropathological changes in the substantia nigra in schizophrenia but not depression.The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion.Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression.
P2860
Q26822727-9497317C-2D6B-4BE6-8813-76325DFDFEA7Q28269179-3DDDE5CC-D7B1-43B7-B149-A1C56387C363Q28290605-41AD56C1-CDED-4D79-84C8-EB3163645FA4Q34364901-9CEE2B72-4277-4290-BC71-6241A2B0B3EAQ35203638-906C873C-F2CB-4C94-BBCF-79F6C6650E9BQ35899165-EE5CFCC4-0B35-4794-B96D-48FB1FAFA120Q36235515-621E39E8-38A5-4F1A-A423-9B2AE99D5E38Q37362447-A87F263E-0F19-4FBF-93D1-83C85C2F0C7EQ38260259-0EE8D874-ADA5-4B0B-84BF-F303E956DE8CQ38434302-D98BE633-9F95-4701-9BE1-856B2FAC9774Q38642339-B3123A6F-1114-4A46-BD37-63687A68FF5FQ38836831-7431E2B6-2CEA-4573-A044-2BEEA59EB2E2Q40093821-641786EF-6A72-4F22-A918-65602212EE65Q40945375-913E7EDB-892C-4965-9C3B-2FAF2D8D1631Q42451597-D53E65A6-94E2-4B2D-BC58-858A86863A21Q48190081-BE464AC6-4CB9-4DDC-AB39-3EC44A8EB013Q55132660-C90781A0-8A07-4C8A-816E-A87D6A315B38
P2860
Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses.
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Dopaminergic hypothesis for re ...... cting therapeutical responses.
@ast
Dopaminergic hypothesis for re ...... cting therapeutical responses.
@en
Dopaminergic hypothesis for re ...... cting therapeutical responses.
@nl
type
label
Dopaminergic hypothesis for re ...... cting therapeutical responses.
@ast
Dopaminergic hypothesis for re ...... cting therapeutical responses.
@en
Dopaminergic hypothesis for re ...... cting therapeutical responses.
@nl
prefLabel
Dopaminergic hypothesis for re ...... cting therapeutical responses.
@ast
Dopaminergic hypothesis for re ...... cting therapeutical responses.
@en
Dopaminergic hypothesis for re ...... cting therapeutical responses.
@nl
P2093
P2860
P1476
Dopaminergic hypothesis for re ...... cting therapeutical responses.
@en
P2093
Nicoletti G
Raffaele R
Rampello L
P2860
P304
P356
10.1111/J.1600-0447.1991.TB03193.X
P407
P577
1991-12-01T00:00:00Z